2018
Improved utilization of waist‐to‐height ratio in cardiometabolic risk counselling in children: Application of DMAIC strategy
Gupta N, Lteif A, Creo A, Iqbal A, Pittock S, Tebben P, Hansen J, Heyrman M, Spee R, Scanlan‐Hanson L, Kumar S. Improved utilization of waist‐to‐height ratio in cardiometabolic risk counselling in children: Application of DMAIC strategy. Journal Of Evaluation In Clinical Practice 2018, 25: 300-305. PMID: 30378218, DOI: 10.1111/jep.13055.Peer-Reviewed Original ResearchConceptsWaist-to-height ratioMeasurement of WCWaist circumferenceCentral obesityRisk counselingSurrogate markers of central obesityMarker of central obesityQuality improvement projectCardiometabolic risk reductionAmbulatory clinical practiceOutpatient clinic settingIncreased cardiometabolic riskBody mass indexElevated WHtRMulti-disciplinary teamWC measurementsAssessment of childrenCardiometabolic riskImprovement projectWHtRDefine-measure-analyse-improve-controlOutcome measuresPaediatric clinicsMass indexProspective cohortImplementing an Internet‐based Decision Aid in Ethnically Diverse Prenatal Care Settings: Reducing Disparities through Shared Decision Making about Birth after Cesarean
Shorten A, Shorten B, Fagerlin A, Illuzzi J, Kennedy H, Pettker C, Raju D, Whittemore R. Implementing an Internet‐based Decision Aid in Ethnically Diverse Prenatal Care Settings: Reducing Disparities through Shared Decision Making about Birth after Cesarean. Journal Of Midwifery & Women's Health 2018, 63: 625-626. DOI: 10.1111/jmwh.12916.Peer-Reviewed Original ResearchMode of birthPrenatal care settingsPrevious cesareanCare settingsOutpatient clinic settingDecisional conflict scoresDecision aidWidespread clinical implementationElectronic health recordsHealth care decisionsVaginal birthBirth outcomesPregnant womenRepeat cesareanClinic settingCesareanWomen's knowledgeDecisional conflictCare decisionsDecision-making experiencesStudy designBirth optionsHealth recordsWomenClinical implementation
2007
The risk of renal impairment in hormone‐refractory prostate cancer patients with bone metastases treated with zoledronic acid
Oh W, Proctor K, Nakabayashi M, Evan C, Tormey L, Daskivich T, Antràs L, Smith M, Neary M, Duh M. The risk of renal impairment in hormone‐refractory prostate cancer patients with bone metastases treated with zoledronic acid. Cancer 2007, 109: 1090-1096. PMID: 17311345, DOI: 10.1002/cncr.22504.Peer-Reviewed Original ResearchConceptsRisk of renal impairmentHormone-refractory prostate cancerRenal impairmentZoledronic acidHormone-refractory prostate cancer patientsAssociated with renal toxicityHistory of renal diseaseZoledronic acid initiatorsTreat bone metastasesZoledronic acid therapyComprehensive medical record reviewProstate cancer patientsBaseline creatinine valuesTertiary oncology centerCox proportional hazards modelsMedical record reviewProportional hazards modelAndersen-Gill extensionPamidronate useRisk factor analysisBone metastasesPamidronate treatmentProstate cancerOutpatient clinic settingRenal toxicity
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply